A cost effectiveness study on psoriasis drugs in Greece

G. Kokla, P. Galanis, D. Kaitelidou, A. Mehili, H. Plessa, M. Diomidous

Research output: Contribution to journalArticlepeer-review


Psoriasis is defined as a unique inflammatory arthritis affecting the joints and connective tissue and is associated with psoriasis of the skin or nails. The purpose of this study is to measure the Psoriasis Area and Severity Index (PASI) of Greek patients affected by either mild or severe psoriasis. The efficacy of treatment and the assessment of the economic impacts of the disease concomitantly evaluated. The PASI score was found to have an average value of 5.22 (SD = 5.85) and median 3 (minimum value: 0 (no damage foci) - the highest price: 25.20 (severe psoriasis)). Examining the different demographic characteristics of patients with psoriasis was found that there is no correlation between them and the PASI score. Also, gender, age, marital status, and occupation do not differentiate PASI score at the confidence level of 5% (P-value 0.05). Early diagnosis enables effective confrontment of the disease and the selection of appropriate therapeutic pathway. Depending on the type of psoriasis and the patient profile the appropriate type of therapy is selected such us topical therapy, phototherapy, systemic therapy or even the administration of biological drugs.

Original languageEnglish
Pages (from-to)39-48
Number of pages10
JournalEpitheorese Klinikes Farmakologias kai Farmakokinetikes
Issue number1
Publication statusPublished - 2015


  • Drugs
  • Effectiveness study
  • Hellenic people
  • Psoriasis


Dive into the research topics of 'A cost effectiveness study on psoriasis drugs in Greece'. Together they form a unique fingerprint.

Cite this